T Vink
Overview
Explore the profile of T Vink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spaander F, Vink T, Natte R, de Bruijn S
Clin Neurol Neurosurg
. 2014 Sep;
126:123-5.
PMID: 25243974
No abstract available.
2.
Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders
Adan R, Vink T
Eur Neuropsychopharmacol
. 2001 Nov;
11(6):483-90.
PMID: 11704425
The identification of the genetic defect underlying the obese phenotype of the viable yellow mouse, ectopic overexpression of the agouti protein which acts as antagonist at the melanocortin-4 receptor, together...
3.
Damas C, Vink T, Nieuwenhuis H, Sixma J
Thromb Haemost
. 2001 Oct;
86(3):887-93.
PMID: 11583323
GMP-33 is a platelet membrane associated protein that is recognised by RUU-SP 1.77, an antibody raised against activated platelets. GMP-33 is predominantly associated with the membrane of platelet alpha-granules and...
4.
Vink T, Hinney A, van Elburg A, Van Goozen S, Sandkuijl L, Sinke R, et al.
Mol Psychiatry
. 2001 Apr;
6(3):325-8.
PMID: 11326303
Anorexia nervosa (AN) is a life threatening disorder affecting mostly adolescent women. It is a dramatic psychiatric syndrome accompanied by severe weight loss, hyperactivity and neuroendocrine changes (reviewed in Refs...
5.
van der Plas R, Gomes L, Marquart J, Vink T, Meijers J, de Groot P, et al.
Thromb Haemost
. 2001 Jan;
84(6):1005-11.
PMID: 11154106
Binding of von Willebrand Factor (vWF) to sites of vascular injury is the first step of hemostasis. Collagen types I and III are important binding sites for vWF. We have...
6.
Wu Y, Vink T, Schiphorst M, van Zanten G, Ijsseldijk M, de Groot P, et al.
Arterioscler Thromb Vasc Biol
. 2000 Jun;
20(6):1661-7.
PMID: 10845886
We studied the role of von Willebrand Factor (vWF) in platelet thrombus formation in flowing blood by using a perfusion system and mutant forms of vWF lacking either interaction with...
7.
Lankhof H, Damas C, Schiphorst M, Ijsseldijk M, Bracke M, Furlan M, et al.
Thromb Haemost
. 1999 Jul;
81(6):976-83.
PMID: 10404778
Type 2A von Willebrand Disease (vWD) is characterized by the absence of high molecular weight von Willebrand factor (VWF) multimers in plasma which is caused by enhanced extracellular proteolysis or...
8.
Lankhof H, Damas C, Schiphorst M, Ijsseldijk M, Bracke M, Furlan M, et al.
Thromb Haemost
. 1997 May;
77(5):1008-13.
PMID: 9184419
von Willebrand factor (vWF) is a complex multimeric plasma glycoprotein, that plays a critical role in the mediation of platelet adhesion to the damaged vascular wall, and functions as a...
9.
Lankhof H, Damas C, Schiphorst M, Ijsseldijk M, Bracke M, Sixma J, et al.
Blood
. 1997 Apr;
89(8):2766-72.
PMID: 9108394
Type 2B von Willebrand disease (vWD) is characterized by the absence of the very high molecular weight von Willebrand factor (vWF) multimers from plasma, which is caused by spontaneous binding...
10.
Lankhof H, van Hoeij M, Schiphorst M, Bracke M, Wu Y, Ijsseldijk M, et al.
Thromb Haemost
. 1996 Jun;
75(6):950-8.
PMID: 8822592
von Willebrand factor (vWF) mediates platelet adhesion at sites of vascular damage. It acts as a bridge between receptors on platelets and collagens present in the connective tissue. Two collagen...